Clemastine Fumarate in the Treatment of Neurodevelopmental Delays in Williams Syndrome

Clinical trial NCT06315699 · COMPLETED

Trial details

NCT number: NCT06315699
Sponsor: Qilu Hospital of Shandong University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Williams Syndrome Child Neurodevelopmental Delay

Start date: 2024-03-20
Primary completion: 2025-03-02
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.